Pilot Trial of Kinesio Taping in Stage II Cellulite
CELLTAPE
Clinical Evaluation of Kinesio Taping Outcomes in Stage II Cellulite: a Pilot Randomised Controlled Trial
2 other identifiers
interventional
34
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether kinesio taping can improve skin structure and reduce stage II cellulite in women. The study focuses on adult female participants aged 18-45 with stage II cellulite and normal BMI. The main questions it aims to answer are: Does kinesio taping increase dermis density? Does kinesio taping improve low echogenic band (LEB) thickness, an ultrasound marker of skin structure? Researchers will compare an experimental group receiving weekly fan-shaped kinesio tape applications on thighs and buttocks for four weeks to a control group that receives no intervention, to see if kinesio taping improves clinical and instrumental measures of cellulite. Participants will: Undergo baseline and follow-up assessments, including body composition, thigh circumference, cellulite stage scoring, and ultrasound of dermis density and LEB. In the experimental group, receive kinesio taping applied once weekly for four weeks on the buttocks and thighs. Return for re-evaluation immediately after the intervention and four weeks later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedFirst Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedOctober 1, 2025
September 1, 2025
3 months
September 16, 2025
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Low Echogenic Band (LEB) Thickness
LEB thickness, a subepidermal ultrasound marker of skin integrity and cellulite severity, will be measured using high-frequency ultrasound (DermaLab Combo 4).
Baseline to 4 weeks (end of intervention).
Change in Dermis Density
Dermis density will be assessed using high-frequency ultrasound (DermaLab Combo 4) to evaluate changes in skin structure associated with cellulite.
Baseline to 4 weeks (end of intervention).
Secondary Outcomes (8)
Change in Thigh Circumference
Baseline to 4 weeks (end of intervention)
Change in Body Fat Percentage
Baseline to 4 weeks (end of intervention)
Change in Cellulite Stage (Nürnberger-Müller Scale)
Baseline to 4 weeks (end of intervention)
Change in Cellulite Severity (Callegari Soft Plus System)
Baseline to 4 weeks (end of intervention)
Change in Fat Mass (kg)
Baseline to 4 weeks (end of intervention)
- +3 more secondary outcomes
Study Arms (2)
Kinesio taping
EXPERIMENTALParticipants received kinesio taping once weekly for four weeks. Fan-shaped elastic therapeutic tape was applied with 0-15% tension to the thighs and buttocks, including the gluteus maximus, posterior thigh, and anterior thigh, to promote lymphatic drainage, improve microcirculation, and support skin structure.
No intervention
NO INTERVENTIONParticipants in this arm did not receive any intervention during the study period. They completed the same baseline, post-intervention (4 weeks) assessments as the experimental group to allow comparison of outcomes without kinesio taping.
Interventions
Kinesio taping was applied in a fan-shaped pattern once weekly for four consecutive weeks. Elastic therapeutic tape was applied with 0-15% tension to the buttocks and thighs at standardized anatomical points, including the gluteus maximus (above the sacroiliac joint), posterior thigh (gluteal fold), and anterior thigh (above the anterior inferior iliac crest). This protocol was designed to promote lymphatic drainage, improve microcirculation, and enhance dermal density and structure in women with stage II cellulite.
Eligibility Criteria
You may qualify if:
- women,
- aged 18-45,
- with Stage II cellulite,
- normal BMI
You may not qualify if:
- pregnancy,
- edema,
- obesity,
- thrombosis,
- skin infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klaipedos valstybine kolegija
Klaipėda, Lithuania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Zaliene, PhD
Klaipedos valstybine kolegija
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2025
First Posted
October 1, 2025
Study Start
December 1, 2024
Primary Completion
February 28, 2025
Study Completion
May 31, 2025
Last Updated
October 1, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share